CELH
Celsius Holdings, Inc.
CELH has the edge over STRA overall, supported by stronger modeled upside and lower modeled downside.
STRA
Strategic Education, Inc.
STRA trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
STRA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Strong |
STRA's cash flow and balance sheet are currently strong, and its revenue and profitability are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over STRA in the historical PE scenario, which offers more potential upside but is not a forecast.
STRA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.1x | $55.08 | — |
| Cheap | 17x | $2.72 | -95% |
| Fair | 28x | $4.53 | -92% |
| Expensive | 44x | $6.99 | -87% |
| Current | 344x | $55.08 | — |
Historical ranges are pointers, not guarantees.
STRA's PE is in its expensive range at 344x. On analysts' estimates for next year's earnings, today's price would be 9.1x, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over STRA on the outlook, with more favorable earnings and revenue expectations.
STRA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect STRA's earnings and profitability to decline, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
STRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.07 | +3694% |
| Q3 2026 | $0.16 | -97% |
| Q2 2026 | $5.99 | +25% |
| Q1 2026 | $5.65 | +21% |
| Q4 2025 | $5.41 | +16% |
| Q3 2025 | $4.81 | -8.6% |
| Q2 2025 | $4.81 | -1.4% |
| Q1 2025 | $4.68 | +11% |
| Q4 2024 | $4.67 | +60% |
STRA has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over STRA on profitability, with a higher operating margin.
STRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $325.1M | +1.6% |
| Q2 2026 | $337.3M | +4.9% |
| Q1 2026 | $305.9M | +0.8% |
| Q4 2025 | $323.2M | +3.8% |
| Q3 2025 | $319.9M | +4.6% |
| Q2 2025 | $321.5M | +2.9% |
| Q1 2025 | $303.6M | +4.6% |
| Q4 2024 | $311.5M | +2.9% |
STRA's revenue has grown year over year for 14 quarters in a row: $325M last quarter, up 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -27% | -39 points |
| Q2 2026 | 15% | +0.7 points |
| Q1 2026 | 13% | +0.3 points |
| Q4 2025 | 16% | +4.4 points |
| Q3 2025 | 12% | -0.3 points |
| Q2 2025 | 14% | +0.8 points |
| Q1 2025 | 13% | -1.1 points |
| Q4 2024 | 12% | -6.3 points |
STRA's operating margin was −27% last quarter, down 39 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
STRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | -10% |
| Q2 2026 | $15M | -26% |
| Q1 2026 | $77.3M | +35% |
| Q4 2025 | $27M | +477% |
| Q3 2025 | $49.3M | +17% |
| Q2 2025 | $20.4M | +50% |
| Q1 2025 | $57.3M | -16% |
| Q4 2024 | $4.7M | -77% |
STRA has the edge over CELH on cash flow, with stronger typical year-over-year growth.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
STRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.3% | -708K shares |
| 1 year | -9.4% | -2.2M shares |
| 3 years | -12% | -2.8M shares |
| 5 years | -13% | -3.1M shares |
| Available history | -4.8% | -1.1M shares |
STRA has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28.5M |
| Q2 2026 | $32.8M |
| Q1 2026 | $40M |
| Q4 2025 | $44.6M |
| Q3 2025 | $34.3M |
| Q2 2025 | $28M |
| Q1 2025 | $32M |
| Q4 2024 | $6.5M |
STRA spent $146M buying back its own shares over the past year, up 45% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
STRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
STRA has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
STRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.5 | Oversold |
| Stochastic | 5.8 | Oversold |
STRA's weekly RSI is 30 (oversold) and its Stochastic is 6 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over STRA on valuation relative to its sector.
STRA PE vs Consumer Defensive Sector
| Metric | STRA | Sector median | Relative |
|---|---|---|---|
| PE | 344x | 19x | 1,666% above |
| PE % | 100 | 18 | 82 pts above |
STRA is trading at 344x earnings, a 1666% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over STRA on trend strength, trading above more of its moving averages.
STRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.8 | 24% below |
| 20 week MA | $78.0 | 29% below |
| 50 week MA | $79.3 | 31% below |
| 100 week MA | $82.2 | 33% below |
| 200 week MA | $87.1 | 37% below |
STRA is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over STRA on returns for 2026, with the stronger performance.
STRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $156.4 | $97.1 | -38% |
| 2021 | $97.1 | $58.6 | -40% |
| 2022 | $58.6 | $81.5 | +39% |
| 2023 | $81.5 | $92.4 | +13% |
| 2024 | $92.4 | $92.8 | +0.5% |
| 2025 | $92.8 | $81.2 | -13% |
| 2026 YTD | $81.2 | $55.1 | -32% |
STRA has finished lower in three of the last six years. It's down 32% so far in 2026.